AGAcell® on «La Razón»: A Spanish hospital uses stem cells to treat alopecia
A Spanish hospital uses stem cells to treat alopecia Dermatologists at Hospital Clínico San Carlos in Madrid are conducting research using mesenchymal stem cells to treat androgenetic alopecia, the most prevalent form of hair loss. Androgenetic alopecia, also known as common baldness, is a dynamic and progressive hair loss disorder that affects both men and […]
AGAcell® on «El Español»:In four years, we could have a stem cell therapy to end baldness.
In four years, we could have a stem cell therapy to end baldness. A stem cell‑based therapy has succeeded in regenerating the hair of mice with induced androgenetic alopecia. The breakthrough comes from a Spanish research team led by Dr. Eduardo López Bran, Head of Dermatology at Hospital Clínico San Carlos in Madrid. López Bran and his colleagues extracted stem cells from adipose (fat) tissue, cultured […]
AGAcell® on «Antena 3»:Is the end of baldness near? This Spanish stem cell treatment has worked successfully in mice
Is the end of baldness near? This Spanish stem cell treatment has worked successfully in mice The solution to baldness may be closer than ever thanks to Spanish research. The Hospital Clínico San Carlos in Madrid has tested a technique in mice that reverses alopecia. A ray of hope for people who want to end […]
AGAcell® on «RTVE»:A Spanish Study Brings the End of Alopecia Closer
A Spanish Study Brings the End of Alopecia Closer Spanish scientists have set a five-year horizon to potentially put an end to alopecia, following a study conducted at the Hospital Clínico San Carlos in Madrid and recently published in the journal Stem Cell Research & Therapy. The key to success—so far demonstrated in mice—lies in a […]
«Europapress»: Ideeea Tx announces AGAcell, a preclinical investigational cell therapy program for alopecia
Ideeea Tx announces AGAcell, a preclinical investigational cell therapy program for alopecia Ideeea Therapeutics closes a €2.3 million seed funding round to drive the development of advanced therapy medicinal products (ATMPs) with an open science approach and strong clinical impact. Read more: Europa Press
«El Confidencial»: Ideeea Therapeutics announces AGAcell®: An allogeneic cell therapy program in preclinical development for alopecia.
Ideeea Therapeutics announces AGAcell®: an allogeneic cell therapy program in preclinical development for alopecia. Ideeea Therapeutics closes €2.3 million seed round to advance the development of advanced therapy medicinal products with an open science and high clinical impact approach. AGAcell® is a preclinical research program that explores the use of allogeneic mesenchymal stem cells for […]
AGAcell® on «National Geographic»: Spanish researchers make a groundbreaking advance in the fight against alopecia
Spanish researchers make a groundbreaking advance in the fight against alopecia. They have applied a combined treatment of cell therapy and an energizing molecule—marking the first such treatment of its kind to be published worldwide. Clinical trials in humans are expected to begin soon. From the moment a fetus begins to form, the first genetic […]
Ideeea TX on «Expansión»: Ideeea TX secures €2.3 million in funding to address alopecia through stem cell-based therapy.
Biotech firm Ideeea TX raises €2.3 million to combat alopecia using stem cell therapy The biotech company Ideeea Therapeutics has closed a €2.3 million seed funding round, supported by private investors and the Centre for the Development of Industrial Technology and Innovation (CDTI), within the framework of the Perte (Strategic Projects for Economic Recovery and […]
«Hair growth stimulated by allogenic adipose‑derived stem cells supplemented with ATP in a mouse model of dihydrotestosterone‑induced androgenetic alopecia. López Bran et al. Stem Cell Research & Therapy volume 16, Article number: 292 (2025)
Authors: E. López Bran, L. Pozo Pérez, P. Tornero Esteban and M. L. González Morales López Bran et al. Stem Cell Research & Therapy volume 16, Article number: 292 (2025) Background Androgenetic alopecia (AGA), also known as male or female pattern hair loss, is the most prevalent form of alopecia worldwide. Current treatments are based on hormone drugs, topical vasodilators and […]
«Clinical and preclinical approach in AGA treatment: a review of current and new therapies in the regenerative field»
Authors: Lorena Pozo‑Pérez, Pilar Tornero‑Esteban and Eduardo López‑Bran This article conducts a comprehensive review of the most advanced clinical and preclinical approaches in the management of androgenetic alopecia (AGA), highlighting the role of emerging regenerative therapies that go beyond traditional treatments. Stem cell and Platelet-rich plasma (PRP) based therapies are explored, along with pioneering technologies […]